期刊文献+

临床药师参与1例内科ICU患者的药物治疗实践 被引量:1

Practice of Clinical Pharmacists Participating in Drug Treatment for an ICU Patients in Internal Medicine Department
原文传递
导出
摘要 目的:探讨临床药师参与危重感染患者药物治疗的实践方式。方法:回顾性分析临床药师参与1例因侵袭性播散性真菌病导致感染性休克的内科ICU患者的药物治疗过程。患者使用亚胺培南/西司他丁钠、万古霉素、伏立康唑抗感染治疗以及免疫、营养支持治疗纠正患者感染性休克状况,待患者病情稳定后给予降阶梯抗感染治疗以及静脉改口服序贯治疗。结果:最终患者病情好转出院。结论:在实施危重症感染患者的药物治疗时,临床药师能帮助医师权衡利弊、综合评估、选择治疗药物,促进患者的康复。 OBJECTIVE: To investigate the mode of clinical pharmacists participating in drug treatment for patients with severe infection. METHODS: The process of clinical pharmacists participated in drug treatment for a case of septic shock due to invasive disseminated fungal disease in ICU of internal medicine department was analyzed retrospectively. The patient received anti-infective treatment with imipenem/cilastatin sodium, vancomycin, voriconazole and immunity and nutritional support treatment to relieve septic shock. The patient was given de-escalation anti-infective treatment and sequential therapy of oral administration replacing intravenous administration after the disease condition became stable. RESULTS: At the last, the patient recovered and discharged from hospital. CONCLUSIONS: In drug treatment, clinical pharmacists can help doctors to weigh the merits and demerits and comprehensively evaluate the choice of therapeutic drugs. So, the recovery of patients can be promoted well.
出处 《中国药房》 CAS CSCD 2012年第46期4414-4416,共3页 China Pharmacy
关键词 临床药师 侵袭性播散性真菌病 感染性休克 Clinical pharmacist Invasive disseminated fungal disease Septic shock
  • 相关文献

参考文献6

二级参考文献19

  • 1陈朴.乌司他丁治疗重症脓毒症患者的临床疗效分析[J].中国实用内科杂志,2005,25(9):802-804. 被引量:6
  • 2王兵,张畔,曹书华,崔乃杰.中医药对严重脓毒症急性虚证免疫调理作用的临床观察[J].辽宁中医学院学报,2006,8(1):7-9. 被引量:11
  • 3Bond CA, Raehl CL. 2006 national clinical pharmacy ser- vices survey: clinical pharmacy services, collaborative drug management, medication errors, and pharmacy tech- nology[J]. Pharmaeotherapy, 2008,28( 1 ) : 1.
  • 4Dellinger RP,Carlet JM,Masur H,et al.Surviving sepsis campaign guidelines for management of severe sepsis and septic shock[J].Int Care Med,2004,30:535-555.
  • 5Bone RC.Immunologic dissonance:a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome(MODS)[J].Ann Intern Med,1996,125 (8):680-687.
  • 6Hotchkiss RS,Chang KC,Grayson MH,et al.Adoptive transfer of apoptotic splenocytes worsens survival,whereas adoptive transfer of necrotic splenocytes improves survival in sepsis[J].Proc Natl Acad Sci USA,2003,100:6724-6729.
  • 7Chang KC,Unsinger J,Davis CG,et al.Multiple triggers of cell death in sepsis:death receptor and mitochondrial-mediated apoptosis[J].FASEB J,2007,21 (3):708-719.
  • 8Giamarellos-Bourboulis EJ,Tsaganos T,Spyridaki E,et al.Early changes of CD4-positive lymphocytes and NK cells in patients with severe Gram negtive sepsis[J].Crit Care,2006,10 (6):166 -170.
  • 9Volk HD,Reinke P,Krausch D,et al.Monocyte deactivation rationale for a new therapeutic strategy in sepsis[J].Int Care Med,1996,22:474-481.
  • 10Fischer G,Schneider EM,LMoldawer LL,et al.CD64 surface expression on neutrophils is transiently upregulated in patients with septic shock[J].Int Care Med,2001,27(12):1848-1852.

共引文献60

同被引文献14

  • 1Rice TW, Wheeler AP, Bemard GR, et al. A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis[J]. Crit Care Med, 2010, 38 (8) : 1 685.
  • 2Hayakawa M, Katabami K, Wada T, et al. Sivelestat (se- lective neutrophil elastase inhibitor) improves the mortali- ty rate of sepsis associated with both acute respiratory dis- tress syndrome and disseminated intravascular coagula- tion patients[J]. Shock, 2010,33( 1 ) : 14.
  • 3Mokart D, Lambert J, Schnell D, et al. Delayed intensive care unit admission is associated with increased mortality in patients with cancer with acute respiratory failure[J]. LeukLymphoma, 2013,54(8) : 1 724.
  • 4Salehifar E, Ala S, Amini M, et al. The role of clinical pharmacists in the improvement of a pharmacovigilance system: a review of the reported adverse drug reactions during 2004- 2010 in Mazandaran Province of Iran[J]. Journal fPharmaceutical Care, 2013,1 ( 1 ) : 8.
  • 5Seoane L, Winterbottom F, Nash T, et al. Reaching impr- oved outcomes through the innovations of a multi- disci- plinary team: changing process of care for patients with severe sepsis and septic shock[J]. Critical Care Medicine, 2011,39( 12): 100.
  • 6van Diepen S, Cook D J, Jacka M, et al. Critical care car- diology research:a call to action[J]. Circ Cardiovasc Qual Outcomes,2013,6(2) :237.
  • 7Herasevich V, Pieper MS, Pulido J, et al. Enrollment into a time sensitive clinical study in the critical care setting: results from computerized septic shock sniffer implemen- tation[J]. J Am Med lnfirm Assoc, 201 1, 18 ( 5 ) : 639.
  • 8Daley M J, Lat I, Mieure KD, et al. A comparison of ini- tial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock[J]. Ann Pharmacother, 2013,47(3) :301.
  • 9梁英英,钱小毛.重症监护病房呼吸机相关性肺炎的危险因素分析[J].中华医院感染学杂志,2010,20(6):799-800. 被引量:84
  • 10赵慧颖,刘方,吕杰,刘丹,安友仲.N末端前B型利钠肽对严重感染及感染性休克患者预后的预测作用[J].中国危重病急救医学,2011,23(8):467-470. 被引量:22

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部